Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Basiliximab (Primary) ; Antithymocyte globulin
- Indications Liver-kidney transplant rejection
- Focus Pharmacodynamics
- Acronyms TReg Kidney
- 22 Jan 2018 Planned End Date changed from 1 Nov 2017 to 1 Nov 2019.
- 22 Jan 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2019.
- 13 Apr 2016 New trial record